Fundz

UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments

PUBLIC · URGNMar 18, 2021

Amount Raised

$75 Million

Round Type

Grant

PrincetonBiotechnologyHealthcare

Description

UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced that the Company has entered into a strategic funding agreement with RTW Investments, LP and its affiliated entities (“RTW”).

Quick answer

UroGen Pharma raised $75 Million in a Grant round, dated March 18, 2021. UroGen Pharma is based in Princeton, New Jersey, United States.

How much did UroGen Pharma raise?
UroGen Pharma raised $75 Million in a Grant round on March 18, 2021.
What does UroGen Pharma do?
UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options.
Where is UroGen Pharma based and how big is it?
UroGen Pharma is based in Princeton, New Jersey, United States. Fundz records about 300 employees.
Who are the decision-makers at UroGen Pharma?
Fundz holds 4 contacts at UroGen Pharma, including the CFO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as UroGen Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Pharmazz raised $250K on April 29, 2021.
  • Os Therapies raised $6M (Series A) on April 20, 2021.
  • SynerFuse, Inc. raised $3.6M (Seed) on April 20, 2021.
  • Ascendia Pharmaceuticals raised $5M on April 20, 2021.
  • Istari Oncology, Inc. raised $43M on April 20, 2021.
  • Antios Therapeutics Inc. raised $32M on April 19, 2021.

Who to call at UroGen Pharma, and when

A new round usually means UroGen Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day UroGen Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at UroGen Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at UroGen Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

UroGen Pharma

Location

400 Alexander Park Drive

Princeton, New Jersey, United States

About

UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment UroGen Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsGary T., CFO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for UroGen Pharma's next move

See what Strategic adds

UroGen Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.